CC
QURE icon

Centiva Capital’s uniQure QURE Stock Holding History

Centiva Capital’s Portfolio QURE Stock Details QURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29,400
Closed -$1.72M – 1537
2025
Q3 		$1.72M Buy
+29,400
New +$534K 0.02% 401

Other funds holding QURE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Centiva Capital's QURE Position: Q3 2025 in Review

Centiva Capital sold out of uniQure (QURE) in Q3 2025, closing a stake of 50,000 shares — an estimated $908K sold.

Centiva Capital first reported a position in QURE in Q4 2022 and held it in 4 quarters. The position peaked at $697K in Q2 2025. 218 funds tracked by Wall St. Rank hold QURE as of Q3 2025.

  • Centiva Capital reported no remaining uniQure position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 50,000 uniQure shares in Q3 2025, an estimated $908K.
  • Centiva Capital first reported a position in uniQure in Q4 2022 and held it in 4 quarters.
  • Centiva Capital's uniQure position peaked at $697K in Q2 2025.
  • 218 funds tracked by Wall St. Rank held uniQure as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.